Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.58B | $1.67B | $1.78B | $1.94B | $2.08B | $2.14B | $2.13B | $2.26B | $2.43B | $2.53B |
| Revenue growth | — | 5.7% | 7.0% | 8.7% | 7.3% | 2.9% | -0.2% | 6.1% | 7.4% | 4.1% |
| Operating income | $179M | $113M | $244M | $257M | $390M | $343M | $343M | $341M | $366M | $338M |
| Operating margin | 11.3% | 6.8% | 13.7% | 13.3% | 18.7% | 16.0% | 16.1% | 15.0% | 15.1% | 13.4% |
| Net income | $109M | $98.2M | $206M | $220M | $319M | $269M | $250M | $273M | $302M | $265M |
| Net margin | 6.9% | 5.9% | 11.5% | 11.3% | 15.4% | 12.6% | 11.7% | 12.0% | 12.4% | 10.5% |
| EPS (diluted) | $6.48 | $5.86 | $12.23 | $13.31 | $19.48 | $16.85 | $16.53 | $17.93 | $19.89 | $18.34 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $135M | $162M | $287M | $301M | $489M | $309M | $310M | $330M | $417M | $388M |
| Capital expenditures | $39.8M | $64.3M | $52.9M | $53.0M | $58.8M | $58.7M | $57.3M | $56.9M | $49.5M | $62.8M |
| Free cash flow | $95.6M | $98.2M | $234M | $248M | $430M | $250M | $253M | $273M | $368M | $325M |
| Share buybacks | $102M | $94.6M | $159M | $92.6M | $176M | $576M | $115M | $67.7M | $361M | $432M |
| Dividends paid | $16.4M | $17.4M | $18.7M | $19.8M | $21.1M | $22.0M | $22.0M | $23.5M | $27.1M | $31.7M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15.3M | $11.1M | $4.83M | $6.16M | $163M | $32.9M | $74.1M | $264M | $178M | $74.5M |
| Total assets | $880M | $920M | $976M | $1.27B | $1.43B | $1.34B | $1.44B | $1.67B | $1.67B | $1.54B |
| Total liabilities | $356M | $380M | $384M | $542M | $534M | $719M | $643M | $560M | $550M | $559M |
| Long-term debt | $100M | $91.2M | $89.2M | $90.0M | — | $185M | $92.5M | — | — | — |
| Shareholders' equity | $524M | $540M | $591M | $727M | $901M | $623M | $799M | $1.11B | $1.12B | $979M |
| Retained earnings | $958M | $1.04B | $1.23B | $1.43B | $1.72B | $1.97B | $2.20B | $2.45B | $2.72B | $2.96B |
| Shares (wtd avg diluted) | 16.8M | 16.7M | 16.8M | 16.5M | 16.4M | 15.9M | 15.1M | 15.2M | 15.2M | 14.5M |
Every figure is extracted from CHEMED CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.